SUPN logo

Supernus Pharmaceuticals (SUPN) CAPEX

Annual CAPEX

$551.00 K
+$139.00 K+33.74%

December 31, 2023

Summary

Performance

1-Year Change

+33.74%

3-Year Change

-85.07%

5-Year Change

-34.72%

15-Year Change

-72.84%

SUPN CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.11%
SUPN annual capital expenditures is higher than 28.11% of companies in Healthcare sector

High & Low

All-time High

$3.69 M
SUPN annual capital expenditures is currently -85.07% below its historical high of $3.69 million

3-Year Low

$412.00 K
SUPN annual capital expenditures is currently +33.74% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SUPN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 25, 2025
SUPN next annual earnings announcement is scheduled for Feb 25, 2025

OtherSUPNcash flowmetrics:

Annual FCF

$110.53 M
SUPN annual free cash flow is $110.53 million

Annual CFO

$111.08 M
SUPN annual cash flow from operations is $111.08 million

Annual CFI

$268.73 M
SUPN annual cash flow from investing activities is $268.73 million

Annual CFF

-$397.88 M
SUPN annual cash flow from financing activities is -$397.88 million

Quarterly CAPEX

$200.00 K
+$136.00 K+212.50%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

SUPN Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.13%
SUPN quarterly capital expenditures is higher than 37.13% of companies in Healthcare sector

High & Low

All-time High

$2.54 M
SUPN quarterly capital expenditures is currently -92.12% below its historical high of $2.54 million

3-Year Low

-$576.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SUPN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 25, 2025
SUPN next earnings announcement is scheduled for Feb 25, 2025

OtherSUPNcash flowmetrics:

Quarterly FCF

$53.32 M
SUPN quarterly free cash flow is $53.32 million

Quarterly CFO

$53.52 M
SUPN quarterly cash flow from operations is $53.52 million

Quarterly CFI

-$77.01 M
SUPN quarterly cash flow from investing activities is -$77.01 million

Quarterly CFF

$3.08 M
SUPN quarterly cash flow from financing activities is $3.08 million

TTM CAPEX

$476.00 K
+$50.00 K+11.74%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

SUPN TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.29%
SUPN TTM capital expenditures is higher than 25.29% of companies in Healthcare sector

High & Low

All-time High

$4.21 M
SUPN TTM capital expenditures is currently -88.70% below its historical high of $4.21 million

3-Year Low

-$161.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SUPN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 25, 2025
SUPN next earnings announcement is scheduled for Feb 25, 2025

OtherSUPNcash flowmetrics:

TTM FCF

$172.03 M
SUPN TTM free cash flow is $172.03 million

TTM CFO

$172.50 M
SUPN TTM cash flow from operations is $172.50 million

TTM CFI

-$243.21 M
SUPN TTM cash flow from investing activities is -$243.21 million

TTM CFF

$7.39 M
SUPN TTM cash flow from financing activities is $7.39 million

SUPN CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+33.7%0.0%0.0%
3 y3 years-85.1%0.0%0.0%
5 y5 years-34.7%0.0%0.0%

SUPN CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-73.1%+33.7%-76.5%+134.7%-76.7%+395.6%
5 y5-year-85.1%+33.7%-92.1%+134.7%-88.7%+395.6%
alltimeall time-85.1%+308.1%-92.1%+134.7%-88.7%+395.6%

Supernus Pharmaceuticals CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$200.00 K(+212.5%)
$476.00 K(+11.7%)
Jun 2024
-
$64.00 K(-74.2%)
$426.00 K(-18.2%)
Mar 2024
-
$248.00 K(-788.9%)
$521.00 K(-5.4%)
Dec 2023
$551.00 K(+33.7%)
-$36.00 K(-124.0%)
$551.00 K(-4.5%)
Sep 2023
-
$150.00 K(-5.7%)
$577.00 K(+0.5%)
Jun 2023
-
$159.00 K(-42.8%)
$574.00 K(-456.5%)
Mar 2023
-
$278.00 K(-2880.0%)
-$161.00 K(-139.1%)
Dec 2022
$412.00 K(-79.9%)
-$10.00 K(-106.8%)
$412.00 K(-10.8%)
Sep 2022
-
$147.00 K(-125.5%)
$462.00 K(+28.7%)
Jun 2022
-
-$576.00 K(-167.7%)
$359.00 K(-61.6%)
Mar 2022
-
$851.00 K(+2027.5%)
$935.00 K(-54.3%)
Dec 2021
$2.04 M(-44.6%)
$40.00 K(-9.1%)
$2.04 M(-11.9%)
Sep 2021
-
$44.00 K(>+9900.0%)
$2.32 M(-10.0%)
Jun 2021
-
$0.00(-100.0%)
$2.58 M(-17.2%)
Mar 2021
-
$1.96 M(+522.5%)
$3.11 M(-15.6%)
Dec 2020
$3.69 M(+166.0%)
$315.00 K(+4.0%)
$3.69 M(-9.0%)
Sep 2020
-
$303.00 K(-43.4%)
$4.05 M(-3.8%)
Jun 2020
-
$535.00 K(-78.9%)
$4.21 M(+13.8%)
Mar 2020
-
$2.54 M(+273.1%)
$3.70 M(+167.0%)
Dec 2019
$1.39 M(+64.3%)
$680.00 K(+47.2%)
$1.39 M(+72.7%)
Sep 2019
-
$462.00 K(+1825.0%)
$803.00 K(+50.9%)
Jun 2019
-
$24.00 K(-89.1%)
$532.00 K(-34.5%)
Mar 2019
-
$221.00 K(+130.2%)
$812.00 K(-3.8%)
Dec 2018
$844.00 K(-58.4%)
$96.00 K(-49.7%)
$844.00 K(-43.9%)
Sep 2018
-
$191.00 K(-37.2%)
$1.50 M(-13.3%)
Jun 2018
-
$304.00 K(+20.2%)
$1.73 M(-12.5%)
Mar 2018
-
$253.00 K(-66.5%)
$1.98 M(-2.3%)
Dec 2017
$2.03 M
$756.00 K(+79.6%)
$2.03 M(+28.9%)
Sep 2017
-
$421.00 K(-23.7%)
$1.57 M(+1.4%)
DateAnnualQuarterlyTTM
Jun 2017
-
$552.00 K(+84.0%)
$1.55 M(-4.4%)
Mar 2017
-
$300.00 K(-0.3%)
$1.62 M(+1.3%)
Dec 2016
$1.60 M(-23.8%)
$301.00 K(-24.6%)
$1.60 M(-26.0%)
Sep 2016
-
$399.00 K(-36.1%)
$2.17 M(-2.9%)
Jun 2016
-
$624.00 K(+123.7%)
$2.23 M(+1.6%)
Mar 2016
-
$279.00 K(-67.7%)
$2.19 M(+4.3%)
Dec 2015
$2.10 M(+254.8%)
$864.00 K(+86.6%)
$2.10 M(+54.9%)
Sep 2015
-
$463.00 K(-21.3%)
$1.36 M(+37.3%)
Jun 2015
-
$588.00 K(+211.1%)
$989.00 K(+90.6%)
Mar 2015
-
$189.00 K(+60.2%)
$519.00 K(-12.5%)
Dec 2014
$593.00 K(-64.0%)
$118.00 K(+25.5%)
$593.00 K(+47.9%)
Sep 2014
-
$94.00 K(-20.3%)
$401.00 K(-59.5%)
Jun 2014
-
$118.00 K(-55.1%)
$990.00 K(-35.6%)
Mar 2014
-
$263.00 K(-455.4%)
$1.54 M(-6.6%)
Dec 2013
$1.65 M(+118.6%)
-$74.00 K(-110.8%)
$1.65 M(-14.3%)
Sep 2013
-
$683.00 K(+2.7%)
$1.92 M(+17.8%)
Jun 2013
-
$665.00 K(+78.8%)
$1.63 M(+50.2%)
Mar 2013
-
$372.00 K(+86.0%)
$1.08 M(+44.1%)
Dec 2012
$753.00 K(+9.9%)
$200.00 K(-49.1%)
$753.00 K(+1.2%)
Sep 2012
-
$393.00 K(+227.5%)
$744.00 K(+73.4%)
Jun 2012
-
$120.00 K(+200.0%)
$429.00 K(-17.8%)
Mar 2012
-
$40.00 K(-79.1%)
$522.00 K(-23.8%)
Dec 2011
$685.00 K(+133.0%)
$191.00 K(+144.9%)
$685.00 K(+38.7%)
Sep 2011
-
$78.00 K(-63.4%)
$494.00 K(+18.8%)
Jun 2011
-
$213.00 K(+4.9%)
$416.00 K(+104.9%)
Mar 2011
-
$203.00 K
$203.00 K
Dec 2010
$294.00 K(-58.8%)
-
-
Dec 2009
$714.00 K(+428.9%)
-
-
Dec 2008
$135.00 K(-87.3%)
-
-
Dec 2007
$1.06 M
-
-

FAQ

  • What is Supernus Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual CAPEX year-on-year change?
  • What is Supernus Pharmaceuticals quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals quarterly CAPEX year-on-year change?
  • What is Supernus Pharmaceuticals TTM capital expenditures?
  • What is the all time high TTM CAPEX for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals TTM CAPEX year-on-year change?

What is Supernus Pharmaceuticals annual capital expenditures?

The current annual CAPEX of SUPN is $551.00 K

What is the all time high annual CAPEX for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual capital expenditures is $3.69 M

What is Supernus Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, SUPN annual capital expenditures has changed by +$139.00 K (+33.74%)

What is Supernus Pharmaceuticals quarterly capital expenditures?

The current quarterly CAPEX of SUPN is $200.00 K

What is the all time high quarterly CAPEX for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly capital expenditures is $2.54 M

What is Supernus Pharmaceuticals quarterly CAPEX year-on-year change?

Over the past year, SUPN quarterly capital expenditures has changed by $0.00 (0.00%)

What is Supernus Pharmaceuticals TTM capital expenditures?

The current TTM CAPEX of SUPN is $476.00 K

What is the all time high TTM CAPEX for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high TTM capital expenditures is $4.21 M

What is Supernus Pharmaceuticals TTM CAPEX year-on-year change?

Over the past year, SUPN TTM capital expenditures has changed by $0.00 (0.00%)